There’s a new drug in town. Saphris (asenaphine), an atypical antipsychotic made by Schering-Plough has been approved for treatment of schizophrenia and Bipolar Disorder. Like most mental-health drugs, Saphris comes with all the potential side effects, such as weight gain. But it’s a new option!
Shared via AddThis